Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Morelli

Showing results (11-20 of 161) with videos related to

Pageof 17
Sort By:
JAMA|February 19, 2020
Selepressin for Patients With Septic ShockSebastian Rehberg, Andrea Morelli, Gerrit Jansen
Critical Care Medicine|September 22, 2007
Ten years of vasopressin research in septic shock: constant dripping wears the stoneAndrea Morelli, Christian Ertmer, Martin Westphal
Critical Care Medicine|October 23, 2008
Vasopressin and the kidney: two false friends?Christian Ertmer, Andrea Morelli, Martin Westphal
Circulation|September 12, 2007
Letter by Guarracino et al regarding article, "Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships"Fabio Guarracino, Luigi Tritapepe, Andrea Morelli
Critical Care Medicine|June 4, 2008
Calcium sensitizing in sepsis: is levosimendan on the right path?Andrea Morelli, Christian Ertmer, Martin Westphal
JAMA|February 20, 2014
Short-acting β-blocker administration in patients with septic shock--replyAndrea Morelli, Christian Ertmer, Mervyn Singer
Journal of Thoracic Disease|January 10, 2017
Esmolol in septic shock: old pathophysiological concepts, an old drug, perhaps a new hemodynamic strategy in the right patientAndrea Morelli, Filippo Sanfilippo, Salvatore Mario Romano
Critical Care Medicine|April 11, 2007
Dear levosimendan, the right ventricle will thank you!Martin Westphal, Andrea Morelli, Hugo Van Aken
Critical Care Medicine|July 16, 2019
The authors replyAndrea Morelli, Filippo Sanfilippo, Sebastian Rehberg, et al.
Current Infectious Disease Reports|August 9, 2008
Current place of vasopressin analogues in the treatment of septic shockChristian Ertmer, Sebastian Rehberg, Andrea Morelli, et al.
Pageof 17

Showing results (11-20 of 161) with videos related to

Sort By:
Pageof 17
JAMA|February 19, 2020
Selepressin for Patients With Septic ShockSebastian Rehberg, Andrea Morelli, Gerrit Jansen
Critical Care Medicine|September 22, 2007
Ten years of vasopressin research in septic shock: constant dripping wears the stoneAndrea Morelli, Christian Ertmer, Martin Westphal
Critical Care Medicine|October 23, 2008
Vasopressin and the kidney: two false friends?Christian Ertmer, Andrea Morelli, Martin Westphal
Circulation|September 12, 2007
Letter by Guarracino et al regarding article, "Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships"Fabio Guarracino, Luigi Tritapepe, Andrea Morelli
Critical Care Medicine|June 4, 2008
Calcium sensitizing in sepsis: is levosimendan on the right path?Andrea Morelli, Christian Ertmer, Martin Westphal
JAMA|February 20, 2014
Short-acting β-blocker administration in patients with septic shock--replyAndrea Morelli, Christian Ertmer, Mervyn Singer
Journal of Thoracic Disease|January 10, 2017
Esmolol in septic shock: old pathophysiological concepts, an old drug, perhaps a new hemodynamic strategy in the right patientAndrea Morelli, Filippo Sanfilippo, Salvatore Mario Romano
Critical Care Medicine|April 11, 2007
Dear levosimendan, the right ventricle will thank you!Martin Westphal, Andrea Morelli, Hugo Van Aken
Critical Care Medicine|July 16, 2019
The authors replyAndrea Morelli, Filippo Sanfilippo, Sebastian Rehberg, et al.
Current Infectious Disease Reports|August 9, 2008
Current place of vasopressin analogues in the treatment of septic shockChristian Ertmer, Sebastian Rehberg, Andrea Morelli, et al.
Pageof 17